Yalcindag, F. NiluferGungor, Sirel GurDegirmenci, Mehmet Fatih KaganSezenoz, Almila SarigulOzcaklar, Zeynep BirsinBaskin, EsraYalcinkaya, Fatma FatosAtilla, Huban2020-10-152020-10-1520190927-3948http://hdl.handle.net/11727/4913Purpose: To report the manifestations, patterns of disease, treatment strategies and outcomes in pediatric patients with noninfectious uveitis. Methods: Demographic information of 76 cases was recorded. Symptoms, anatomic location, laterality, visual acuity (VA), intraocular pressure, associated systemic diseases, therapeutic strategies, side effects, complications were reviewed. Results: Thirty-one patients were diagnosed as uveitis on routine surveillance because of underlying systemic disease. The most common anatomic location was intermediate uveitis (34.2%). Juvenile idiopathic arthritis (JIA) was the most common underlying systemic disease (25%). Glaucoma was the most common complication (7.7%). The patients with refractory uveitis received adalimumab (26.5%), infliximab (4.6%) and tocilizumab (3.1%). The mean first-year VA was between 20/32 and 20/20 in 116/140 eyes. Conclusion: Most pediatric noninfectious uveitis cases have bilateral intermediate uveitis. JIA was the most common systemic association. The first-year VA was good in most eyes which may be due to early use of corticosteroid-sparing agents.enginfo:eu-repo/semantics/closedAccessBiologic agentsjuvenile idiopathic arthritisnoninfectious uveitispars planitispediatric uveitisarticle0004945072000012-s2.0-85074774620